|
US2012276100A1
|
|
Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
|
|
US2013306700A1
|
|
Stapler with leg-flattening and anvil-limiting capability
|
|
US2012093769A1
|
|
Dock-and-Lock (DNL) Complexes for Disease Therapy
|
|
US2012082685A1
|
|
Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy
|
|
US2011300066A1
|
|
Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases
|
|
US2011300105A1
|
|
Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivo
|
|
US2011158905A1
|
|
Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
|
|
US2011123436A1
|
|
Dock-and-lock (DNL) complexes for delivery of interference RNA
|
|
US2011274704A1
|
|
Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity
|
|
US2010189641A1
|
|
Strategies for improved cancer vaccines
|
|
WO2004094613A2
|
|
Polyvalent protein complex
|
